NCT02651077

Brief Summary

The investigators wish to highlight, in a Case-Control design, if there is an increased concentration of BFRs in omental adipose tissue of cases ( women with severe endometriosis with surgical indication ) versus bioaccumulation recorded in a control cohort ( women recruited in obstetrics and gynecology or visceral surgery showing no sign of endometriosis ) . Pairing will be operate on Age (+/- 5 years compared to the case ) , BMI ( BMI 5 Classes described by the HAS) and previous breastfeeding experience (yes / no , opposite the release expected bioaccumulate contaminants in breast adipose tissue , when the lactation ) .

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2013

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2013

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2014

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

January 6, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 8, 2016

Completed
Last Updated

January 8, 2016

Status Verified

January 1, 2016

Enrollment Period

1 year

First QC Date

January 6, 2016

Last Update Submit

January 7, 2016

Conditions

Keywords

Endometriosis, chemical contaminants, BFRs

Outcome Measures

Primary Outcomes (1)

  • Concentrations of brominated flame retardant (BFR) in adipose tissue and serum

    baseline

Secondary Outcomes (3)

  • Concentrations of dioxins in adipose tissue and serum

    baseline

  • Concentrations of polychlorinated biphenyls (PCBs),

    baseline

  • Concentrations of organochlorine pesticides (OCPs) in adipose tissue and serum

    baseline

Study Arms (2)

Case Group

38 women with severe and deep endometriosis, aged 18 to 45 years old and hospitalized at Nantes University Hospital for surgical indication of endometriosis lesions ablation.

Control Group

38 women aged 18 to 45 years old without suggestive signs of endometriosis

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

38 women with severe and deep endometriosis, aged 18 to 45 years old and hospitalized at Nantes University Hospital for surgical indication of endometriosis lesions ablation. And 38 women aged 18 to 45 years old without suggestive signs of endometriosis

Inclusion criterion for de cases : * Age : 18-45 years old * Deep endometriosis with or without endometriomas that need surgery (clinical examination, MRI, surgery) * Accessing to the omental and/or parietal adipose tissue * Non opposition of the patients for the samples collection and consent for the present study. Inclusion criterion for the controls : * Patients without any history of endometriosis and without suggestive symptomatology. Often patients operated for cesarean section. * Possible access to the adipose tissue of the omentum or abdominal wall Exclusion criterion for the cases : * Pregnancy * Death Exclusion criterion for controls : * Pregnancy * Death

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

Nantes University Hospital

Nantes, 44093, France

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

omental adipose tissue

MeSH Terms

Conditions

Endometriosis

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

  • Stephane PLOTEAU, Dr

    Nantes University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 6, 2016

First Posted

January 8, 2016

Study Start

November 1, 2013

Primary Completion

November 1, 2014

Study Completion

November 1, 2014

Last Updated

January 8, 2016

Record last verified: 2016-01

Locations